Aspirin strategy for secondary prevention of atherosclerotic cardiovascular diseases: A narrative review
Aspirin is the most used antiplatelet agent for secondary prophylaxis of atherosclerotic cardiovascular diseases. Individual variability in aspirin responsiveness has been widely reported. The current recommendations do not take these variations into consideration. Current guidelines recommend 75–10...
Main Authors: | Nischal N Hegde, Navin Mathew |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
Series: | Journal of the Practice of Cardiovascular Sciences |
Subjects: | |
Online Access: | http://www.j-pcs.org/article.asp?issn=2395-5414;year=2023;volume=9;issue=2;spage=99;epage=103;aulast=Hegde |
Similar Items
-
Aspirin : the miracle drug /
by: 296334 Metcalf, Eric
Published: (2005) -
US population qualifying for aspirin use for primary prevention of cardiovascular disease
by: Athena L. Huang, et al.
Published: (2024-06-01) -
Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Patients Treated With P2Y12 Inhibitors
by: Saket Girotra, et al.
Published: (2023-10-01) -
Aspirin tablets
by: 982 SIRIM -
Prevention of preeclampsia using low dose Aspirin: A randomised controlled trial
by: Aseel Mosa Jabber
Published: (2019-04-01)